Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations—CONCORDE BayeSize applies the concept of effect size ...
Two Phase 3 clinical trials testing the experimental therapy TNX-103 in people with PH-HFpEF are currently recruiting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback